Volume 11, Issue 44 (3-2005)
RJMS 2005, 11(44): 945-950 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rasi A, Soltani Arabshahi R, Setareh Shenas R. Kaposi’s Sarcoma after Immunosuppressive Therapy for Bullous Pemphigoid: A Case Report. RJMS 2005; 11 (44) :945-950
URL: http://rjms.iums.ac.ir/article-1-94-en.html
URL: http://rjms.iums.ac.ir/article-1-94-en.html
Abstract: (8696 Views)
Kaposi’s sarcoma is a malignant neoplasm of lymphatic and blood vessels endothelial cells. The disease is classified into four clinical subtypes, all of which are associated with human herpes virus 8(HHV-8). We report a 71-year-old man who was treated for six months with prednisolone and azathioprine for bullous pemphigoid and presented with multiple purple papules and plaques on ear, nose and fingers. Pathology of the lesions revealed Kaposi’s sarcoma. Subsequently, the dose of azathioprine was lowered. There are few reported cases of Kaposi’s sarcoma after immunosuppressive therapy for bullous pemphigoid and in some of these cases the pathogenic role of HHV-8 has been documented.
Type of Study: Research |
Subject:
Dermatology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
